MCRB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Seres Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.98 USD -5.26%

Market Cap: $19.2m

	Seres Therapeutics Inc NASDAQ:MCRB	US
D	DENTSPLY SIRONA Inc DUS:DY2	US
	Biomerieux SA PAR:BIM	FR
N	Novo Nordisk A/S OTC:NONOF	DK
	Oil-Dri Corporation of America NYSE:ODC	US
	Supernus Pharmaceuticals Inc NASDAQ:SUPN	US
P	Pan American Silver Corp F:PA2	CA
	Lundin Gold Inc TSX:LUG	CA
P	Planisware SA PAR:PLNW	FR
	BHP Group Ltd ASX:BHP	AU
Q	Qingdao Port International Co Ltd F:0QP	CN
	Apple Hospitality REIT Inc F:48T	US
	AES Corp NYSE:AES	US

Profitability Summary

Seres Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-4 154%

Negative 3Y Average Operating Margin

-10 645%

Declining Operating Margin

-55% > -4 154%

Negative Net Margin

-1 193%

Negative 3Y Average Net Margin

-618%

Declining Net Margin

-112% > -1 193%

Negative Free Cash Flow Margin

-2 724%

Negative 3Y Average Free Cash Flow Margin

-2 606%

Declining Free Cash Flow Margin

-106% > -2 724%

Negative ROE

-67%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-81%

Declining ROIC

-54% > -86%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.